Characterization of seizures induced by acute and repeated exposure to tetramethylenedisulfotetramine

Dorota Zolkowska, Christopher N. Banks, Ashish Dhir, Bora Inceoglu, James R. Sanborn, Mark R. McCoy, Donald A. Bruun, Bruce D. Hammock, Pamela J Lein, Michael A Rogawski

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Tetramethylenedisulfotetramine (tetramine; TETS) is a potent convulsant poison that is considered to be a chemical threat agent. To provide a basis for the investigation of antidotes for TETS-induced seizures, we characterized the convulsant activity of TETS in mice and rats when administered by the intraperitoneal, intravenous, oral, and intraventricular routes as a single acute dose and with repeated sublethal doses. In mice, parenteral and oral TETS caused immobility, myoclonic body jerks, clonic seizures of the forelimbs and/or hindlimbs, tonic seizures, and death. The CD 50 values for clonic and tonic seizures after oral administration were 0.11 and 0.22 mg/kg, respectively. Intraventricular administration of TETS (5-100 μg) in rats also caused clonic-tonic seizures and death. In mice, repeated sublethal doses of TETS at intervals of 2, 24, and 48 h failed to result in the development of persistent enhanced seizure responsivity ("kindling") as was observed with repeated pentylenetetrazol treatment. In mice, sublethal doses of TETS that produced clonic seizures did not cause observable structural brain damage as assessed with routine histology and Fluoro-Jade B staining 7 days after treatment. However, 1 to 3 days after a single convulsant dose of TETS the expression of glial fibrillary acidic protein, an astrocyte marker, and ionized calcium binding adaptor molecule 1, a microglia marker, were markedly increased in cortex and hippocampus. Although TETS doses that are compatible with survival are not associated with overt evidence of cellular injury or neurodegeneration, there is transient reactive astrocytosis and microglial activation, indicating that brain inflammatory responses are provoked.

Original languageEnglish (US)
Pages (from-to)435-446
Number of pages12
JournalJournal of Pharmacology and Experimental Therapeutics
Volume341
Issue number2
DOIs
StatePublished - May 1 2012

Fingerprint

tetramethylenedisulfotetramine
Seizures
Convulsants
Antidotes
Pentylenetetrazole
Myoclonus
Gliosis
Forelimb
Poisons
Glial Fibrillary Acidic Protein
Brain
Microglia
Hindlimb
Astrocytes
Oral Administration

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine

Cite this

Characterization of seizures induced by acute and repeated exposure to tetramethylenedisulfotetramine. / Zolkowska, Dorota; Banks, Christopher N.; Dhir, Ashish; Inceoglu, Bora; Sanborn, James R.; McCoy, Mark R.; Bruun, Donald A.; Hammock, Bruce D.; Lein, Pamela J; Rogawski, Michael A.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 341, No. 2, 01.05.2012, p. 435-446.

Research output: Contribution to journalArticle

Zolkowska, Dorota ; Banks, Christopher N. ; Dhir, Ashish ; Inceoglu, Bora ; Sanborn, James R. ; McCoy, Mark R. ; Bruun, Donald A. ; Hammock, Bruce D. ; Lein, Pamela J ; Rogawski, Michael A. / Characterization of seizures induced by acute and repeated exposure to tetramethylenedisulfotetramine. In: Journal of Pharmacology and Experimental Therapeutics. 2012 ; Vol. 341, No. 2. pp. 435-446.
@article{d66c08ddcbd248ef91968ce83bd664ff,
title = "Characterization of seizures induced by acute and repeated exposure to tetramethylenedisulfotetramine",
abstract = "Tetramethylenedisulfotetramine (tetramine; TETS) is a potent convulsant poison that is considered to be a chemical threat agent. To provide a basis for the investigation of antidotes for TETS-induced seizures, we characterized the convulsant activity of TETS in mice and rats when administered by the intraperitoneal, intravenous, oral, and intraventricular routes as a single acute dose and with repeated sublethal doses. In mice, parenteral and oral TETS caused immobility, myoclonic body jerks, clonic seizures of the forelimbs and/or hindlimbs, tonic seizures, and death. The CD 50 values for clonic and tonic seizures after oral administration were 0.11 and 0.22 mg/kg, respectively. Intraventricular administration of TETS (5-100 μg) in rats also caused clonic-tonic seizures and death. In mice, repeated sublethal doses of TETS at intervals of 2, 24, and 48 h failed to result in the development of persistent enhanced seizure responsivity ({"}kindling{"}) as was observed with repeated pentylenetetrazol treatment. In mice, sublethal doses of TETS that produced clonic seizures did not cause observable structural brain damage as assessed with routine histology and Fluoro-Jade B staining 7 days after treatment. However, 1 to 3 days after a single convulsant dose of TETS the expression of glial fibrillary acidic protein, an astrocyte marker, and ionized calcium binding adaptor molecule 1, a microglia marker, were markedly increased in cortex and hippocampus. Although TETS doses that are compatible with survival are not associated with overt evidence of cellular injury or neurodegeneration, there is transient reactive astrocytosis and microglial activation, indicating that brain inflammatory responses are provoked.",
author = "Dorota Zolkowska and Banks, {Christopher N.} and Ashish Dhir and Bora Inceoglu and Sanborn, {James R.} and McCoy, {Mark R.} and Bruun, {Donald A.} and Hammock, {Bruce D.} and Lein, {Pamela J} and Rogawski, {Michael A}",
year = "2012",
month = "5",
day = "1",
doi = "10.1124/jpet.111.190579",
language = "English (US)",
volume = "341",
pages = "435--446",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Characterization of seizures induced by acute and repeated exposure to tetramethylenedisulfotetramine

AU - Zolkowska, Dorota

AU - Banks, Christopher N.

AU - Dhir, Ashish

AU - Inceoglu, Bora

AU - Sanborn, James R.

AU - McCoy, Mark R.

AU - Bruun, Donald A.

AU - Hammock, Bruce D.

AU - Lein, Pamela J

AU - Rogawski, Michael A

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Tetramethylenedisulfotetramine (tetramine; TETS) is a potent convulsant poison that is considered to be a chemical threat agent. To provide a basis for the investigation of antidotes for TETS-induced seizures, we characterized the convulsant activity of TETS in mice and rats when administered by the intraperitoneal, intravenous, oral, and intraventricular routes as a single acute dose and with repeated sublethal doses. In mice, parenteral and oral TETS caused immobility, myoclonic body jerks, clonic seizures of the forelimbs and/or hindlimbs, tonic seizures, and death. The CD 50 values for clonic and tonic seizures after oral administration were 0.11 and 0.22 mg/kg, respectively. Intraventricular administration of TETS (5-100 μg) in rats also caused clonic-tonic seizures and death. In mice, repeated sublethal doses of TETS at intervals of 2, 24, and 48 h failed to result in the development of persistent enhanced seizure responsivity ("kindling") as was observed with repeated pentylenetetrazol treatment. In mice, sublethal doses of TETS that produced clonic seizures did not cause observable structural brain damage as assessed with routine histology and Fluoro-Jade B staining 7 days after treatment. However, 1 to 3 days after a single convulsant dose of TETS the expression of glial fibrillary acidic protein, an astrocyte marker, and ionized calcium binding adaptor molecule 1, a microglia marker, were markedly increased in cortex and hippocampus. Although TETS doses that are compatible with survival are not associated with overt evidence of cellular injury or neurodegeneration, there is transient reactive astrocytosis and microglial activation, indicating that brain inflammatory responses are provoked.

AB - Tetramethylenedisulfotetramine (tetramine; TETS) is a potent convulsant poison that is considered to be a chemical threat agent. To provide a basis for the investigation of antidotes for TETS-induced seizures, we characterized the convulsant activity of TETS in mice and rats when administered by the intraperitoneal, intravenous, oral, and intraventricular routes as a single acute dose and with repeated sublethal doses. In mice, parenteral and oral TETS caused immobility, myoclonic body jerks, clonic seizures of the forelimbs and/or hindlimbs, tonic seizures, and death. The CD 50 values for clonic and tonic seizures after oral administration were 0.11 and 0.22 mg/kg, respectively. Intraventricular administration of TETS (5-100 μg) in rats also caused clonic-tonic seizures and death. In mice, repeated sublethal doses of TETS at intervals of 2, 24, and 48 h failed to result in the development of persistent enhanced seizure responsivity ("kindling") as was observed with repeated pentylenetetrazol treatment. In mice, sublethal doses of TETS that produced clonic seizures did not cause observable structural brain damage as assessed with routine histology and Fluoro-Jade B staining 7 days after treatment. However, 1 to 3 days after a single convulsant dose of TETS the expression of glial fibrillary acidic protein, an astrocyte marker, and ionized calcium binding adaptor molecule 1, a microglia marker, were markedly increased in cortex and hippocampus. Although TETS doses that are compatible with survival are not associated with overt evidence of cellular injury or neurodegeneration, there is transient reactive astrocytosis and microglial activation, indicating that brain inflammatory responses are provoked.

UR - http://www.scopus.com/inward/record.url?scp=84860007164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860007164&partnerID=8YFLogxK

U2 - 10.1124/jpet.111.190579

DO - 10.1124/jpet.111.190579

M3 - Article

VL - 341

SP - 435

EP - 446

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 2

ER -